Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v1-EN
Language French English
Date Updated 2022-06-28 2022-06-10
Drug Identification Number 02169649 02169649
Brand name BETASERON BETASERON
Common or Proper name INTERFERON BETA-1B INTERFERON BETA-1B
Company Name BAYER INC BAYER INC
Ingredients INTERFERON BETA-1B INTERFERON BETA-1B
Strength(s) 0.3MG 0.3MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS
Packaging size 15 Single Use Pack 15 Single Use Pack
ATC code L03AB L03AB
ATC description IMMUNOSTIMULANTS IMMUNOSTIMULANTS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2022-07-01 2022-07-01
Actual start date
Estimated end date 2022-07-05 2022-07-05
Actual end date 2022-06-28
Shortage status Avoided shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments